Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/20/15 → 9/30/17 |
Funding
- Pharm Olam International: $152,264.00
14-GI-94-OI (OX4219S) Rollover fosbretabulin study in NET patients with elevated biomarkers
- Anthony, Lowell (PI)
| Status | Finished |
|---|---|
| Effective start/end date | 4/20/15 → 9/30/17 |